SCHEMBL9424464

SCHEMBL9424464

CCc1ccc(S(=O)(=O)NC(=O)Nc2ccc(Cl)cc2)s1.[NaH]

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 7/20 0.47
MEN1 O00255 6/20 0.47
KLKB1 P03952 1/20 0.47
CTSB P07858 1/20 0.47
ELANE P08246 1/20 0.47
ALDH1A1 P00352 3/20 0.47
POLB P06746 3/20 0.46
RAB9A P51151 2/20 0.46
HTT P42858 2/20 0.45
IDH1 O75874 1/20 0.43
MAPT P10636 3/20 0.42
CA12 O43570 3/20 0.42
CA1 P00915 3/20 0.42
CA2 P00918 3/20 0.42
CA9 Q16790 3/20 0.42
RECQL P46063 1/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
LMNA P02545 1/20 0.41
CYP3A4 P08684 1/20 0.41
THRB P10828 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9424478 0.99 KMT2A (0.48) KMT2AMEN1KLKB1CTSBELANE
SCHEMBL9424704 0.90 ALDH1A1 (0.44) KMT2AMEN1KLKB1CTSBELANE
SCHEMBL9424699 0.87 EPHX1 (0.48) KMT2AMEN1ALDH1A1POLBRAB9A
SCHEMBL9424554 0.85 EPHX1 (0.49) KMT2AMEN1ALDH1A1POLBRAB9A
SCHEMBL9424703 0.84 EPHX1 (0.48) KMT2AMEN1ALDH1A1POLBHTT
SCHEMBL9424731 0.82 ALDH1A1 (0.51) KMT2AMEN1ALDH1A1POLBRAB9A
SCHEMBL9424721 0.81 MAPT (0.58) KMT2AMEN1ALDH1A1POLBHTT
SCHEMBL9424517 0.81 KMT2A (0.47) KMT2AMEN1KLKB1CTSBELANE
SCHEMBL9424401 0.80 FBP1 (0.53) KMT2AMEN1KLKB1CTSBELANE
SCHEMBL9424582 0.79 ALDH1A1 (0.43) KMT2AMEN1KLKB1CTSBELANE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5302724-A Thiophenesulfonylureas; anticarcinogenic agents ELI LILLY AND COMPANY (US) 1994-04-12 US disclosed
CN-1058401-A Anti-tumor compositions and methods of treatment LILLY CO ELI (US) 1992-02-05 CN disclosed
EP-0467613-A1 Antitumor compositions and methods of treatment ELI LILLY AND COMPANY (US) 1992-01-22 EP disclosed